Quarterly report pursuant to Section 13 or 15(d)

Inventories

v3.10.0.1
Inventories
6 Months Ended
Jun. 30, 2018
Inventories  
Inventories

3.    Inventories

 

Inventories are comprised of unprocessed tissue, work-in-process, Avance® Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, Avive® Soft Tissue Membrane, AcroVal® Neurosensory and Motor Testing System, AxoTouch® Two-Point Discriminator and supplies and are valued at the lower of cost (first-in, first-out) or net realizable value and consist of the following:

 

 

 

 

 

 

 

 

 

 

    

June 30,

    

December 31,

    

 

 

2018

 

2017

 

 

 

 

 

 

 

Finished goods

 

$

7,173,516

 

$

5,489,360

 

Work in process

 

 

381,840

 

 

470,187

 

Raw materials

 

 

2,126,763

 

 

1,356,395

 

Inventories

 

$

9,682,119

 

$

7,315,942

 

 

For the three months ended June 30, 2018 and 2017, the Company had inventory write-downs of $326,000 and $370,000, respectively, and for the six months ended June 30, 2018 and 2017, the Company had inventory write-downs of $582,000 and $681,000, respectively, relating primarily to product obsolescence.